Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02071485 · ClinicalTrials.gov registry record

Non-Invasive Brain-Computer Interface for Virtual Object Control

A clinical trial of Individuality, sponsored by University of Minnesota.

Completed
Registry status
205
Enrollment target
1
Study location

NCT02071485 is a study of Individuality that has completed, run by University of Minnesota. The registered enrollment target is 205 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02071485, a study of Individuality, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
205 participants
Enrollment target
1
Study location

Study Summary

A brain-computer interface (BCI) is a system that provides a separate output pathway for neurological signals whereby they can be interpreted to determine the user's intended cognitive action. Utilizing EEG-based sensorimotor rhythms (SMRs) generated in the motor cortex has allowed subjects to control virtual computer cursors in up to three dimensions by simply imagining the movement of a specified body part. Nevertheless, the scalp EEG signals are smeared by the volume conduction effect and measurement noise. The overall hypothesis of this study is that EEG-based virtual object control may help reveal optimal motor imagination tasks best used in a BCI. The PI's hypotheses include: (1) The use of advanced signal processing techniques will better reveal characteristics of EEG signals that represent the underlying motor cognitive function of the subject; (2) BCI systems based on SMR generated using motor imaginations will allow effective control of a virtual object in real time; (3) EEG imaging techniques will provide insight into the areas of cortical activation during a motor imagery task that can be utilized to increase the spatial resolution of non-invasive BCI's.

Conditions Studied

Study Locations (1)

Minnesota

  • Nils Hasselmo Hall at the University of Minnesota - Twin Cities campus - Minneapolis

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2014-03
Est. Completion 2018-01-08

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT02071485

The ClinicalTrials.gov registry entry for NCT02071485 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Individuality appearing as the primary indexed condition, and to 0 interventions.

NCT02071485 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02071485 about?

NCT02071485 is a clinical study titled "Non-Invasive Brain-Computer Interface for Virtual Object Control". A brain-computer interface (BCI) is a system that provides a separate output pathway for neurological signals whereby they can be interpreted to determine the user's intended cognitive action. Utilizing EEG-based sensorimotor rhythms (SMRs) generated in the motor cortex has allowed subjects to contr...

What is the current status of trial NCT02071485?

This trial is currently completed. The enrollment target is 205 participants. The study started on 2014-03. Estimated completion is 2018-01-08.

What conditions does trial NCT02071485 study?

This clinical trial studies the following conditions: Individuality.

Who is sponsoring clinical trial NCT02071485?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02071485 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.